Atra stock nasdaq

Nov 01, 2019 · Atara Biotherapeutics Inc. company facts, information and stock details by MarketWatch. View atra business summary and other industry information.

Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases Atara Biotherapeutics, Inc. Common Stock (ATRA ... - Nasdaq ATRA's NASDAQ Last Sale (NLS) "Last Sale" is the price at which a stock last traded during regular market hours. NLS Volume "Volume" is the number of shares of the stock traded on the listing exchange during regular trading hours. Previous Close Today's High / Low 52 Week High / Low ATRA Stock Price | Atara Biotherapeutics Inc. Stock Quote ... ATRA | Complete Atara Biotherapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Stock To Watch: Atara Biotherapeutics (ATRA) | Nasdaq Feb 11, 2020 · (RTTNews) - Atara Biotherapeutics Inc. (ATRA) has some key milestones lined up for this year, making it a stock worth watching. Atara is focused on developing off-the-shelf, allogeneic T-cell

Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases

Atara Biotherapeutics is traded on the NASDAQ stock exchange under the symbol “ATRA”. When did Atara Biotherapeutics go public? Atara Biotherapeutics went public on October 15, 2014. How can I purchase shares? Shares can be purchased through a stockbroker of your choice. Does Atara Biotherapeutics have a direct stock purchase plan? ATRA | Stock Snapshot - Fidelity Apr 03, 2020 · Stock quote and company snapshot for ATARA BIOTHERAPEUTICS INC (ATRA), including profile, stock chart, recent news and events, analyst opinions, and research reports. Here’s Why Atara Biotherapeutics, Inc. (ATRA) Is A Stock ... Mar 17, 2020 · On Monday, shares of Atara Biotherapeutics, Inc. (NASDAQ:ATRA) marked $6.14 per share versus a previous $8.32 closing price. With having a -26.20% loss, an insight into the fundamental values of Atara Biotherapeutics, Inc., investors would also find a great ally in the technical patterns of the stock movements showed in stock charts. Atara Biotherapeutics Inc Historical Data - ATRA | ADVFN

Stock To Watch: Atara Biotherapeutics (ATRA) | Nasdaq

ATRA stock quote, chart and news. Get Atara Biotherapeutics, Inc.'s stock price today. Atara Biotherapeutics (ATRA) Investor Presentation ... Feb 27, 2020 · The following slide deck was published by Atara Biotherapeutics, Inc. in conjunction with this event. ATRA Stock | ATARA BIOTHERAPEUTICS Stock Price Today ... ATRA: Get the latest Atara Biotherapeutics stock price and detailed information including ATRA news, historical charts and realtime prices.

ATRA Stock Price, Forecast & News (Atara Biotherapeutics)

Atara Biotherapeutics Inc is a company in the U.S. stock market and it is a holding in 38 U.S.-traded ETFs. ATRA has around 4.6M shares in the U.S. ETF market. Atara Biotherapeutics Inc (ATRA) Quote | Morningstar Mar 24, 2020 · Learn about ATRA with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to …

Atara Biotherapeutics (ATRA) Investor Presentation ...

Atara Biotherap stocks price quote with latest real-time prices, charts, financials, Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule   Mar-26-20 10:19AM, Is Atara Biotherapeutics (NASDAQ:ATRA) In A Good Position To Deliver On Growth Plans? Simply Wall St. +6.76%. Feb-28-20 07: 04AM  11 Dec 2019 Atara Biotherapeutics Inc (NASDAQ:ATRA) is not the most popular stock in this group but hedge fund interest is still above average. This is a  27 Sep 2019 The shares of drugmaker Atara Biotherapeutics Inc (NASDAQ:ATRA) are hurting today, following a scathing bear note from Goldman Sachs. 6 Jan 2020 Atara Biotherapeutics (NASDAQ:ATRA) is developing novel treatments for patients with cancer, autoimmune and viral diseases. Specifically  6 Aug 2018 (Nasdaq:ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer,  Our ATRA ETF report shows the ETFs with the most ATRA exposure, the top to ATRA stock is Loncar Cancer Immunotherapy ETF (CNCR), with a portfolio weight of 3.28%. UBIO, ProShares UltraPro Nasdaq Biotechnology, 4.46%.

Atara Biotherapeutics, Inc. Common Stock (ATRA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Find the latest news headlines from Atara Biotherapeutics, Inc. Common Stock ( ATRA) at Nasdaq.com. 6 days ago Atara Biotherapeutics, Inc. Common Stock (ATRA) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and  (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral  Researching Atara Biotherapeutics (NASDAQ:ATRA) stock? View ATRA's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC  View live ATARA BIOTHERAPEUTICS INC chart to track its stock's price action. Find market predictions, ATRA financials and market news.